Notably, PIK3CA gene mutations are the most common somatic genetic changes in ER+ BC and are associated with favorable features, such as smaller tumor size, lower grade, estrogen receptor positivity and older patient age [46]. The gene discussed is ESR1; the disease is breast cancer.